Hang Li

4.6k citations

86 papers · 3.0k · 2 hit papers · h-index 27

Impact in

Pulmonary and Respiratory Medicine top 1%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Oncology top 2%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies

Papers in

Pulmonary and Respiratory Medicine 38
- Lung Cancer Treatments and Mutations 26
- Lung Cancer Diagnosis and Treatment 12
Oncology 14
- Lung Cancer Research Studies 4
- Colorectal Cancer Treatments and Studies 4

Co-authors: Yuan Li (31 shared papers)Yunjian Pan (32 shared papers)Yihua Sun (36 shared papers)Haichuan Hu (23 shared papers)Yang Zhang (24 shared papers)H. Chen (24 shared papers)Lei Shen (19 shared papers)Ting Ye (20 shared papers)
Journals: OncoTargets and Therapy (5 papers)Journal of Thoracic Oncology (5 papers)Annals of Surgical Oncology (5 papers)Lung Cancer (3 papers)Journal of Cancer Research and Clinical Oncology (3 papers)
Partner nations: China United States Germany

In The Last Decade

Hang Li

84 papers receiving 3.0k citations

Hang Li's Hit Papers

align trajectories log scale

Development of a novel combined nomogram model integrating deep learning-pathomics, radiomics and immunoscore to predict postoperative outcome of colorectal cancer lung metastasis patients 2022 · 180 citations

What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

2022 Journal of Hematology & Oncology
2012 Journal of Clinical Oncology

Peers

Countries citing papers authored by Hang Li

Since Specialization

Citations

This map shows the geographic impact of Hang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hang Li more than expected).

Fields of papers citing papers by Hang Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hang Li. The network helps show where Hang Li may publish in the future.

Co-authors

The 25 scholars most cited alongside Hang Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hang Li Line = papers co-authored together Hang Li links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 86 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	RET Fusions Define a Unique Molecular and Clinicopathologic Subtype of Non–Small-Cell Lung Cancer Journal of Clinical Oncology ·Rui Wang, Haichuan Hu, Yunjian Pan, Yuan Li, Ting Ye, Chenguang Li, Xiaoyang Luo, Lei Wang, Hang Li, Yang Zhang, Fei Li, Yongming Lu, Qiong Lu, Jie Xu, David H. Garfield, Lei Shen, Hongbin Ji, William J. Pao, Yihua Sun, H. Chen Hit paper breakdown →	2012	450
2	Protein expression of programmed death 1 ligand 1 and ligand 2 independently predict poor prognosis in surgically resected lung adenocarcinoma OncoTargets and Therapy ·Yang Zhang, Lei Wang, Yuan Li, Yunjian Pan, Haichuan Hu, Hang Li, Xiaoyang Luo, Ting Ye, yihua sun, haiquan chen, Rui Ting Wang	2014	194
3	ALK, ROS1 and RET fusions in 1139 lung adenocarcinomas: A comprehensive study of common and fusion pattern-specific clinicopathologic, histologic and cytologic features Lung Cancer ·Yunjian Pan, Yang Zhang, Yuan Li, Haichuan Hu, Lei Wang, Hang Li, Rui Wang, Ting Ye, Xiaoyang Luo, Yiliang Zhang, Bin Li, Deng Cai, Lei Shen, Yihua Sun, Haiquan Chen	2014	192
4	Development of a novel combined nomogram model integrating deep learning-pathomics, radiomics and immunoscore to predict postoperative outcome of colorectal cancer lung metastasis patients Journal of Hematology & Oncology ·Renjie Wang, Weixing Dai, Jing Gong, Mingzhu Huang, Tingdan Hu, Hang Li, Kailin Lin, Cong Tan, Hong Hu, Tong Tong, Guoxiang Cai Hit paper breakdown →	2022	180
5	Esm1 Modulates Endothelial Tip Cell Behavior and Vascular Permeability by Enhancing VEGF Bioavailability Circulation Research ·Susana Ferreira Rocha, Maria Schiller, (unknown), Hang Li, Stefan Butz, Dietmar Vestweber, Daniel Biljes, Hannes C. A. Drexler, Melina Nieminen-Kelhä, Peter Vajkoczy, Susanne Adams, Rui Benedito, Ralf H. Adams	2014	171
6	Frequency of Driver Mutations in Lung Adenocarcinoma from Female Never-Smokers Varies with Histologic Subtypes and Age at Diagnosis Clinical Cancer Research ·Yang Zhang, Yihua Sun, Yunjian Pan, Chenguang Li, Lei Shen, Yuan Li, Xiaoyang Luo, Ting Ye, Rui Wang, Haichuan Hu, Hang Li, Lei Wang, William J. Pao, H. Chen	2012	154
7	PIK3CA Mutations Frequently Coexist with EGFR/KRAS Mutations in Non-Small Cell Lung Cancer and Suggest Poor Prognosis in EGFR/KRAS Wildtype Subgroup PLoS ONE ·Lei Wang, Haichuan Hu, Yunjian Pan, Rui Wang, Yuan Li, Lei Shen, Yongfu Yu, Hang Li, Deng Cai, Yihua Sun, H. Chen	2014	134
8	FGFR1/3 Tyrosine Kinase Fusions Define a Unique Molecular Subtype of Non–Small Cell Lung Cancer Clinical Cancer Research ·Rui Wang, Lei Wang, Yuan Li, Haichuan Hu, Lei Shen, Xuxia Shen, Yunjian Pan, Ting Ye, Yang Zhang, Xiaoyang Luo, Yiliang Zhang, Bin Pan, Bin Li, Hang Li, Jie Zhang, William J. Pao, Hongbin Ji, Yihua Sun, Haiquan Chen	2014	123
9	Minor Components of Micropapillary and Solid Subtypes in Lung Adenocarcinoma are Predictors of Lymph Node Metastasis and Poor Prognosis Annals of Surgical Oncology ·Y. Zhao, R. Wang, Xuxia Shen, Yunjian Pan, Chao Cheng, Yuan Li, Lei Shen, Yang Zhang, Hang Li, Difan Zheng, Ting Ye, Shanbo Zheng, Yihua Sun, H. Chen	2016	121
10	Frequency of well-identified oncogenic driver mutations in lung adenocarcinoma of smokers varies with histological subtypes and graduated smoking dose Lung Cancer ·Hang Li, Yunjian Pan, Yuan Li, Chenguang Li, Rui Wang, Haichuan Hu, Yang Zhang, Ting Ye, Lei Wang, Lei Shen, Yihua Sun, H. Chen	2012	88
11	The Use of Quantitative Real-Time Reverse Transcriptase PCR for 5′ and 3′ Portions of ALK Transcripts to Detect ALK Rearrangements in Lung Cancers Clinical Cancer Research ·Rui Wang, Yunjian Pan, Chenguang Li, Haichuan Hu, Yang Zhang, Hang Li, Xiaoyang Luo, Jie Zhang, Zhaoyuan Fang, Yuan Li, Lei Shen, Hongbin Ji, David Garfield, Yihua Sun, H. Chen	2012	76
12	A Comprehensive Investigation of Molecular Features and Prognosis of Lung Adenocarcinoma with Micropapillary Component Journal of Thoracic Oncology ·Y. Zhang, Rui Wang, Deng Cai, Yuan Li, Yunjian Pan, Haichuan Hu, Lei Wang, Hang Li, Ting Ye, Xiaoyang Luo, Yiliang Zhang, Bin Li, Lei Shen, Yihua Sun, H. Chen	2014	72
13	Detection of Novel NRG1, EGFR, and MET Fusions in Lung Adenocarcinomas in the Chinese Population Journal of Thoracic Oncology ·Yunjian Pan, Yang Zhang, Ting Ye, Y. Zhao, Zhendong Gao, Hui Yuan, Difan Zheng, Shanbo Zheng, Hang Li, Yuan Li, Yan Jin, Yihua Sun, H. Chen	2019	58
14	Analysis of Major Known Driver Mutations and Prognosis in Resected Adenosquamous Lung Carcinomas Journal of Thoracic Oncology ·Rui Wang, Yunjian Pan, Chenguang Li, Huibiao Zhang, David H. Garfield, Yuan Li, Ting Ye, Haichuan Hu, Xiaoyang Luo, Hang Li, Yang Zhang, Jie Zhang, Xiaoyan Zhou, Lei Shen, William J. Pao, Yihua Sun, H. Chen	2014	49
15	Negative Thyroid Transcription Factor 1 Expression Defines an Unfavorable Subgroup of Lung Adenocarcinomas Journal of Thoracic Oncology ·Yiliang Zhang, Rui Wang, Yuan Li, Yunjian Pan, Haichuan Hu, Yang Zhang, Hang Li, Lei Shen, Yongfu Yu, Yihua Sun, H. Chen	2015	47
16	The prognostic and predictive value of solid subtype in invasive lung adenocarcinoma Scientific Reports ·Yang Zhang, Jing Li, Rui Wang, Yuan Li, Yunjian Pan, Deng Cai, Haichuan Hu, Hang Li, Ting Ye, Xiaoyang Luo, Yiliang Zhang, Bin Li, Lei Shen, Yihua Sun, Haiquan Chen	2014	45
17	Oncogenic mutations are associated with histological subtypes but do not have an independent prognostic value in lung adenocarcinoma OncoTargets and Therapy ·Haichuan Hu, H. Chen, Yunjian Pan, Yuan Li, Lei Wang, Rui Wang, Yang Zhang, Hang Li, Ting Ye, Yiliang Zhang, Xiaoyang Luo, Longlong Shao, Zhengliang Sun, Deng Cai, Jie Xu, Qiong Lu, (unknown), Lei Shen, Hongbin Ji, yihua sun	2014	41
18	Lead exposure and its interactions with oxidative stress polymorphisms on lung function impairment: Results from a longitudinal population-based study Environmental Research ·Wei Wei, Xiulong Wu, Yansen Bai, Guyanan Li, Yue Feng, Hua Meng, Hang Li, Mengying Li, Xiaomin Zhang, Meian He, Huan Guo	2020	39
19	The prevalence and prognostic significance of KRAS mutation subtypes in lung adenocarcinomas from Chinese populations OncoTargets and Therapy ·Difan Zheng, H. Chen, Rui Wang, Y. Zhang, Yunjian Pan, Xinghua Cheng, Chao Cheng, Shanbo Zheng, Hang Li, Ranxia Gong, Yuan Li, Xuxia Shen, Yihua Sun	2016	39
20	Tumor histology predicts mediastinal nodal status and may be used to guide limited lymphadenectomy in patients with clinical stage I non–small cell lung cancer Journal of Thoracic and Cardiovascular Surgery ·Xinghua Cheng, Difan Zheng, Yuan Li, Hang Li, Yihua Sun, Jiaqing Xiang, H. Chen	2018	36

About Hang Li

Hang Li is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Rehabilitation, Biomaterials and Molecular Biology, having authored 86 papers that have together received 3.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (26 papers), Lung Cancer Diagnosis and Treatment (12 papers), Lung Cancer Research Studies (4 papers), Colorectal Cancer Treatments and Studies (4 papers), Electrospun Nanofibers in Biomedical Applications (3 papers), Wound Healing and Treatments (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.6k citations), Oncology (918 citations), Cancer Research (488 citations), Molecular Biology (711 citations) and Pathology and Forensic Medicine (134 citations). Hang Li has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Yuan Li, Yunjian Pan, Yihua Sun, Haichuan Hu, Yang Zhang, H. Chen, Lei Shen, Ting Ye, Rui Wang and Xiaoyang Luo. Their work appears in journals such as OncoTargets and Therapy, Journal of Thoracic Oncology, Annals of Surgical Oncology, Lung Cancer and Journal of Cancer Research and Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Hang Li

Impact in

Papers in i

In The Last Decade

Hang Li

Hang Li's Hit Papers

Peers

Countries citing papers authored by Hang Li

Fields of papers citing papers by Hang Li

All Works

About Hang Li

Explore authors with similar magnitude of impact

Papers in